Scher
Andreas Scher, Burgdorf DE
Patent application number | Description | Published |
---|---|---|
20150352912 | METHOD FOR ASSOCIATING TIRE POSITIONS ON A VEHICLE HAVING A TIRE PRESSURE MONITORING SYSTEM - A method via which tire modules can be associated with tire positions on a vehicle includes: inputting vehicle data and tire information via a mobile detecting device; analyzing the input information via the detecting device; providing an instruction to the user of the detecting device indicating the first tire for performing a first tire module identification; positioning the detecting device near the first tire which is specified by the detecting device; activating an inquiry signal having a transmission frequency specified by the detecting device and a specified signal amplitude to a tire module arranged in the tire, wherein the tire module includes at least one sensor for tire-pressure monitoring; capturing a response signal from the tire module, wherein the response includes the identification data of the tire module; and, evaluating the response signal of the tire module and associating the identified tire module with a tire position. | 12-10-2015 |
David S. Scher, Collieville, TN US
Patent application number | Description | Published |
---|---|---|
20150197488 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE - A method of making an amino acid triisocyanate is provided, the method comprising reacting an amino acid trihydrochloride with phosgene to form the amino acid triisocyanate. In some embodiments, the amino acid trihydrochloride comprises lysine ester trihydrochloride salt and the amino acid triisocyanate comprises lysine ester triisocyanate. In some embodiments, there is a lysine ester triisocyanate having a purity of at least about 98%, the lysine ester triisocyanate having a structure resulting from reacting lysine ester trihydrochloride salt with phosgene to form the lysine ester triisocyanate. These lysine ester triisocyanates can be used to make biodegradable polyurethanes. | 07-16-2015 |
David S. Scher, Hudson, MA US
Patent application number | Description | Published |
---|---|---|
20100272811 | COMPLEX OF TROSPIUM AND PHARMACEUTICAL COMPOSITIONS THEREOF - The invention is directed to a complex of trospium and saccharin. In one embodiment, the complex is a crystalline form. In another embodiment, the complex is a monohydrate form. The invention also encompasses methods of preparing the the saccharin complex of trospium and to pharmaceutical compositions thereof. | 10-28-2010 |
David S. Scher, Collierville, TN US
Patent application number | Description | Published |
---|---|---|
20140212921 | CELL CULTURES AND METHODS OF HUMAN RECOMBINANT GROWTH AND DIFFERENTIATON FACTOR-5 (RHGDF-5) - A cell cuture media for plasmid production is provided for increased production of a recombinant GDF-5 (rhGDF-5) protein. Also provided herein is a method of making a cell culture media for plasmid production and a method for growing a plasmid vector. The methods of enhancing production and protein expression of rhGDF-5 protein as disclosed are cost-effective, time-saving and are of manufacturing quality. | 07-31-2014 |
20140212924 | HUMAN RECOMBINANT GROWTH AND DIFFERENTIATON FACTOR-5 (RHGDF-5) - Expression vector systems are provided for increased production of a recombinant GDF-5 (rhGDF-5) protein. Also provided are transformed host cells that were engineered to produce and express high levels of rhGDF-5 protein. Methods for production and high expression of rhGDF-5 protein are disclosed herein. The methods of enhancing production and protein expression of rhGDF-5 protein as disclosed are cost-effective, time-saving and are of manufacturing quality. | 07-31-2014 |
20140212951 | EXPRESSION CONDITIONS AND METHODS OF HUMAN RECOMBINANT GROWTH AND DIFFERENTIATON FACTOR-5 (RHGDF-5) - A cell culture media for growing transformant pGDF-5-Trc-transformed cells is provided for increased production of transformant pGDF-5-Trc-transformed cells. Also provided herein are methods of growing the transformant pGDF-5-Trc-transformed cells. The methods of growing the transformant pGDF-5-Trc-transformed cells as disclosed are cost-effective, time-saving and are of manufacturing quality. | 07-31-2014 |
20140212952 | METHODS AND COMPOSITIONS OF HUMAN RECOMBINANT GROWTH AND DIFFERENTIATON FACTOR-5 (RHGDF-5) ISOLATED FROM INCLUSION BODIES - Expression vector systems are provided for increased production of a recombinant GDF-5 (rhGDF-5) protein. Also provided are transformed host cells that were engineered to produce and express high levels of rhGDF-5 protein. Methods for isolating recombinant GDF-5 protein from an inclusion body of a cell are disclosed herein. The methods as disclosed are cost-effective, time-saving and are of manufacturing quality. | 07-31-2014 |
20140213776 | METHODS AND COMPOSITIONS COMPRISING HUMAN RECOMBINANT GROWTH AND DIFFERENTIATON FACTOR-5 (RHGDF-5) - Expression vector systems are provided for increased production of a recombinant GDF-5 (rhGDF-5) protein. Also provided are transformed host cells that were engineered to produce and express high levels of rhGDF-5 protein. Methods for production and high expression of rhGDF-5 protein are disclosed herein. The methods of enhancing production and protein expression of rhGDF-5 protein as disclosed are cost-effective, time-saving and are of manufacturing quality. | 07-31-2014 |
20150197483 | METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE - In some embodiments, a method of making an amino acid trihydrochloride is provided, the method comprising reacting an amino acid monohydrochloride with an alkanolamine to form the amino acid trihydrochloride. In some embodiments, the amino acid monohydrochloride comprises lysine hydrochloride, which is mixed with ethanolamine to form lysine ester trihydrochloride. In some embodiments, there is a lysine ester trihydrochloride salt having a purity of at least about 98%, the lysine ester trihydrochloride salt having a structure resulting from reacting lysine hydrochloride and ethanolamine to form the lysine ester trihydrochloride salt. The lysine ester trihydrochloride can be made in one reaction vessel. | 07-16-2015 |
20150252088 | METHODS AND COMPOSITIONS COMPRISING HUMAN RECOMBINANT GROWTH AND DIFFERENTIATION FACTOR-5 (RHGDF-5) - Expression vector systems are provided for increased production of a recombinant GDF-5 (rhGDF-5) protein. Also provided are transformed host cells that were engineered to produce and express high levels of rhGDF-5 protein. Methods for production and high expression of rhGDF-5 protein are disclosed herein. The methods of enhancing production and protein expression of rhGDF-5 protein as disclosed are cost-effective, time-saving and are of manufacturing quality. | 09-10-2015 |
Erick C. Scher, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20140107385 | OXIDATIVE COUPLING OF METHANE SYSTEMS AND METHODS - Systems and methods conducive to the formation of one or more alkene hydrocarbons using a methane source and an oxidant in an oxidative coupling of methane (OCM) reaction are provided. One or more vessels each containing one or more catalyst beds containing one or more catalysts each having similar or differing chemical composition or physical form may be used. The one or more catalyst beds may be operated under a variety of conditions. At least a portion of the catalyst beds may be operated under substantially adiabatic conditions. At least a portion of the catalyst beds may be operated under substantially isothermal conditions. | 04-17-2014 |
Herbert B. Scher, Moraga, CA US
Patent application number | Description | Published |
---|---|---|
20090010890 | STORAGE STABLE COMPOSITIONS OF BIOLOGICAL MATERIALS - Storage stable compositions of biological materials, including bioactive biological materials are provided in the form of a water-in-oil emulsion, comprising: | 01-08-2009 |
20100286019 | Spray Drying Process - The present invention generally relates to particulate compositions and methods for making the compositions. It specifically relates to improved spray drying methods that substantially reduce the production of small particles that pose industrial hygiene concerns for factory workers and product consumers. In a composition aspect, the present invention provides an atomized aqueous composition. The composition is formed using a spray-drying apparatus. It includes 0.001 to 0.10 weight percent of a polymer, which is selected from a group consisting of a cellulose-based polymer, a gum, and a synthetic polymer. It further includes at least one polypeptide, which is present in the aqueous composition at a concentration greater than 0.01 weight percent. | 11-11-2010 |
20120309664 | Spray Drying Process - The present invention generally relates to particulate compositions and methods for making the compositions. It specifically relates to improved spray drying methods that substantially reduce the production of small particles that pose industrial hygiene concerns for factory workers and product consumers. In a composition aspect, the present invention provides an atomized aqueous composition. The composition is formed using a spray-drying apparatus. It includes 0.001 to 0.10 weight percent of a polymer, which is selected from a group consisting of a cellulose-based polymer, a gum, and a synthetic polymer. It further includes at least one polypeptide, which is present in the aqueous composition at a concentration greater than 0.01 weight percent. | 12-06-2012 |
20140348815 | SPRAY DRY METHOD FOR ENCAPSULATION OF BIOLOGICAL MOIETIES AND CHEMICALS IN POLYMERS CROSS-LINKED BY MULTIVALENT IONS FOR CONTROLLED RELEASE APPLICATIONS - Microencapsulation of bioactive and chemical cargo in a stable, cross-linked polymer matrix is presented that results in small particle sizes and is easily scaled-up for industrial applications. A formulation of a salt of an acid soluble multivalent ion, an acid neutralized with a volatile base and one or more monomers that cross-link in the presence of multivalent ions is atomized into droplets. Cross-linking is achieved upon atomization where the volatile base is vaporized resulting in a reduction of the pH of the formulation and the temporal release of multivalent ions from the salt that cross-link the monomers forming a capsule. The incorporation of additional polymers or hydrophobic compounds in the formulation allows control of hydration properties of the particles to control the release of the encapsulated compounds. The operational parameters can also be controlled to affect capsule properties such as particle-size and particle-size distribution. | 11-27-2014 |
20150079299 | AEROSOL COATING PROCESS BASED ON VOLATILE, NON-FLAMMABLE SOLVENTS - A method for coating target surfaces by spraying an atomized liquid formulation of a volatile solvent, a dispersant, and adhesion promoter, a polymer, a plasticizer and particulates of an active material and vaporizing the solvent from the spray droplets to form deformable solid particles in flight that impact the target surface to form a coating. The temperature of the atomizing gas used to form the spray and the liquid formulation temperatures can be manipulated to accelerate or decelerate the evaporation of solvent and balance the heat of vaporization of the solvent in the spray liquid so that condensation of ambient vapors in the atmosphere surrounding the deposition target is prevented. | 03-19-2015 |
Howard Scher, Tenafly, NJ US
Patent application number | Description | Published |
---|---|---|
20150191792 | GENE EXPRESSION PROFILE ASSOCIATED WITH PROSTATE CANCER - Using an RT-PCR platform, detection of gene transcripts highly expressed in prostate tissue and expressed in peripheral blood mononuclear cells (PBMC) from patients with mCRPC can provide a more reliable and robust prediction of poor overall survival than that of CTC enumeration in mCRPC. Disclosed is the identification of five genes, KLK3, KLK2, HOXB13, GHRL2 and FOXA1, the detection of two (2) or more transcripts of which predicts overall poor survival. The test is performed on blood samples that have been collected in collection tubes that stabilize intracellular RNA, require minimal on-site processing and can be easily stored and shipped for subsequent extraction of total RNA from whole blood for RT-PCR. | 07-09-2015 |
Howard I. Scher, Tenafly, NJ US
Patent application number | Description | Published |
---|---|---|
20150240314 | GENES ASSOCIATED WITH DASATINIB SENSITIVITY - The invention relates to a method for the Cell Type specific labeling with Amino acid Precursors (CTAP). In particular, the disclosed method permits the incorporation of stable isotope-labeled amino acids into the proteome of a vertebrate cell that has been engineered to express an exogenous enzyme that enables the cell to produce an essential amino acid from its amino acid substrate. The method employs stable isotope-labeled amino acid substrate/precursors from which essential amino acids bearing the label are generated. The labeled amino acids generated by the transgenic cell not only supports growth but specifically labels proteins of the transgenic cell. Furthermore, the use of different populations of cells expressing different exogenous amino acid-producing enzymes permits differential labeling of the proteomes of the individual cell populations in multicellular environments. | 08-27-2015 |
Irwin Scher, Wynnewood, PA US
Patent application number | Description | Published |
---|---|---|
20110236399 | COMPOSITIONS AND METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTION - This invention is directed to compositions and methods for treating (e.g., prophylactically and/or therapeutically) infection in a preterm infant. In particular, the invention provides anti-lipoteichoic acid (LTA) antibody compositions and methods of administering the same to a preterm infant (e.g., a low birth weight preterm infant (e.g., a very low birth weight preterm infant)) under conditions to establish anti-LTA antibody serum concentrations effective to kill and/or prevent growth of bacteria (e.g., Staphylococci). Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine) and research applications. | 09-29-2011 |
Joan Scher, Sylacauga, AL US
Patent application number | Description | Published |
---|---|---|
20100006494 | BIO-RESISTANT FILTER COALESCER CARTRIDGE - A filter coalescer cartridge for treating jet fuels is disclosed. The filter coalescer cartridge has spaced apart filter/coalescer layers to effectively remove particulate contaminates and water from the transient fuel being treated. The outer most layer is a knitted sock material formed from cotton threads including a metallic silver disposed thereon to provide an anti-microbial property to the sock material. | 01-14-2010 |
Jochen Matthias Scher, Warthausen DE
Patent application number | Description | Published |
---|---|---|
20130266646 | PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS - The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 | 10-10-2013 |
John D. Scher, Aliso Viego, CA US
Patent application number | Description | Published |
---|---|---|
20130226628 | EVENT-CENTRIC MATCHING AND SOCIAL NETWORKING SERVICES - Methods for matching a first user of an online service site to a second user for jointly attending an event of mutual interest are disclosed. A first event query is received from the first user. In response, a first event listing including the event of mutual interest is transmitted to the first computer system. A selection of this event is received, together with an admission matching proposal therefor. A corresponding admission availability entry is added to an event announcement page, which is subsequently transmitted to a second user. If the second user so desires and so selects, then an admission matching offer is received by the online service site. | 08-29-2013 |
Jose U. Scher, Jersey City, NJ US
Patent application number | Description | Published |
---|---|---|
20150374760 | METHODS FOR TREATING PSORIASIS AND PSORIATIC ARTHRITIS - Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) and psoriasis (Ps) are encompassed herein, as are methods for identifying pathogenic dysbiosis in a subject, the presence of which is a positive indicator of risk for developing PsA or of the presence of PsA in a subject with arthritic symptoms. | 12-31-2015 |
Michael Scher, Lawrenceville, NJ US
Patent application number | Description | Published |
---|---|---|
20130224738 | DETECTING DNA METHYLATION OF BCL2, CDKN2A AND NID2 GENES TO PREDICT BLADDER CANCER IN HUMANS - The present invention provides a method of detecting DNA methylation of a plurality of genes consisting of CDKN2A, BCL2 and NID2 in a urine sample from a human. Methods and compositions are provided herein for detecting and diagnosing bladder cancer by obtaining a urine sample from a human subject suspected of bladder cancer, followed by detecting DNA methylation of CDKN2A, BCL2 AND NID2 in urine samples from the individual. The present method permits specific detection of DNA methylation of the selected gene promoters in urine as a biomarker for bladder cancer in humans. | 08-29-2013 |
Robert Scher, Annandale, VA US
Patent application number | Description | Published |
---|---|---|
20090038532 | Ship and associated methods of formation with vessels connectable between decks and hulls - A ship and associated methods of operation. In an example embodiment, a method of operating a ship includes providing multiple vessels each having a first deck attached to two spaced-apart hull sections. The deck and hull sections define a cavity when the vessel is afloat. A plurality of like coupling mechanisms are provided, each suitable for joining two of the vessels. First and second vessels are joined along starboard and port sides of the deck of the second vessel with one of the coupling mechanisms. Joining is effected by attaching a first of the hull sections on the first vessel to the deck of the second vessel along the port side of the second vessel, and attaching a second of the hull sections on the first vessel to the deck of the second vessel along the starboard side of the second vessel. When coupled to one another the deck of the second vessel is positioned between the first and second hull sections of the first vessel. Attaching of the first vessel to the second vessel includes positioning of a first pin between the first hull section and the deck of the second vessel and positioning of a second pin between the second hull section and the deck of the second vessel. The first coupling mechanism limits movement of the first and second vessels, with respect to one another, to movement about a single axis of rotation, this permitting the first vessel to undergo changes in pitch relative to the second vessel. | 02-12-2009 |
20100263955 | SURFACE EFFECT SEA TRAIN - A multiple unit surface effect vehicle movable through an aquatic environment is provided including connected units and lift fans. The multiple unit surface effect vehicle may further include a coupling system and/or a plurality of skirt portions connecting one of the connected units with another of the connected units. The multiple unit surface effect vehicle includes the connected units connected to form a continuous movable unit movable in an aquatic environment. Each connected unit includes a forced air containment chamber defined within each of the connected units. The forced air containment chambers of each of the connected units are connected to form a continuous pressurized air cushion. The lift fans force air into the forced air containment chamber to pressurize the continuous pressurized air cushion. | 10-21-2010 |
Steven Scher, Chula Vista, CA US
Patent application number | Description | Published |
---|---|---|
20150062315 | SIMULTANEOUS 2D AND 3D IMAGES ON A DISPLAY - Many 3D displays show 3D images to viewers wearing special eyeglasses, while showing a double image to viewers without eyeglasses ( | 03-05-2015 |
Susan Scher, Reisterstown, MD US
Patent application number | Description | Published |
---|---|---|
20120084192 | System and Method for Coordinated Sales and Implementation of Financial Products - Systems and methods for the coordinated sales and implementation of financial products are disclosed. In accordance with embodiments of the present disclosure, an apparatus may include a network interface and a processor coupled to the network interface. The network interface may be configured to receive a request for a client's purchase of a financial product, the request including client information. The processor may be configured to execute logic to (i) generate implementation documents based at least on the client information, the implementation documents comprising documents to be completed as a prerequisite to issuance of the financial product; (ii) schedule a follow-up meeting relating to purchase of the financial product based at least on the client information; and (iii) contemporaneously electronically display implementation documents to a client and an implementation advisor to facilitate the implementation advisor's assistance to the client in completing the implementation documents. | 04-05-2012 |
Uwe Scher, Cremlingen/destedt DE
Patent application number | Description | Published |
---|---|---|
20090277431 | Internal combustion engine with an exhaust-gas recirculation and method for operating an internal combustion engine - An internal combustion engine has a high-pressure exhaust-gas recirculation line and a low-pressure exhaust-gas recirculation line with a low-pressure exhaust-gas recirculation valve. The low-pressure exhaust-gas recirculation line branches off from the exhaust-gas system downstream of a turbine of an exhaust-gas turbocharger and opens into a fresh-air system upstream of a compressor of the exhaust-gas turbocharger. An exhaust-gas flap is disposed in the exhaust-gas system downstream from where the low-pressure exhaust-gas recirculation line branches off from the exhaust-gas system. At least one pressure sensor is disposed in the low-pressure exhaust-gas recirculation line and configured such that the at least one pressure sensor determines a pressure difference in the low-pressure exhaust-gas recirculation line between a point upstream of the low-pressure exhaust-gas recirculation valve and a point downstream of the low-pressure exhaust-gas recirculation valve. A method for operating an internal combustion engine is also provided. | 11-12-2009 |
20120060499 | Internal combustion engine with an exhaust-gas recirculation and method for operating an internal combustion engine - An internal combustion engine has a high-pressure exhaust-gas recirculation line and a low-pressure exhaust-gas recirculation line with a low-pressure exhaust-gas recirculation valve. The low-pressure exhaust-gas recirculation line branches off from the exhaust-gas system downstream of a turbine of an exhaust-gas turbocharger and opens into a fresh-air system upstream of a compressor of the exhaust-gas turbocharger. An exhaust-gas flap is disposed in the exhaust-gas system downstream from where the low-pressure exhaust-gas recirculation line branches off from the exhaust-gas system. At least one pressure sensor is disposed in the low-pressure exhaust-gas recirculation line and configured such that the at least one pressure sensor determines a pressure difference in the low-pressure exhaust-gas recirculation line between a point upstream of the low-pressure exhaust-gas recirculation valve and a point downstream of the low-pressure exhaust-gas recirculation valve. A method for operating an internal combustion engine is also provided. | 03-15-2012 |